DSpace at EWHA: INFLIXIMAB AS THE FIRST RETREATMENT IN PATIENTS WITH KAWASAKI DISEASE RESISTANT TO INITIAL INTRAVENOUS IMMUNOGLOBULIN

Browse

My Repository

View : 639 Download: 0

Full metadata record

DC Field	Value	Language
dc.contributor.author	홍영미	*
dc.contributor.author	손세정	*
dc.date.accessioned	2016-08-27T04:08:38Z	-
dc.date.available	2016-08-27T04:08:38Z	-
dc.date.issued	2016	*
dc.identifier.issn	0891-3668	*
dc.identifier.issn	1532-0987	*
dc.identifier.other	OAK-16121	*
dc.identifier.uri	https://dspace.ewha.ac.kr/handle/2015.oak/217889	-
dc.description.abstract	Forty-three patients with Kawasaki disease who were resistant to initial intravenous immunoglobulin (IVIG) were randomized to receive either a second dose of IVIG (n = 32) or an infliximab (n = 11). With IVIG retreatment 21 patients (65.6%) responded, and with infliximab 10 patients (90.9%) responded. The infliximab group had shorter duration of fever and fewer days of hospitalization. Coronary artery outcomes and adverse events were similar.	*
dc.language	English	*
dc.publisher	LIPPINCOTT WILLIAMS &amp	*
dc.publisher	WILKINS	*
dc.subject	Kawasaki disease	*
dc.subject	intravenous immunoglobulin	*
dc.subject	infliximab	*
dc.subject	retreatment	*
dc.title	INFLIXIMAB AS THE FIRST RETREATMENT IN PATIENTS WITH KAWASAKI DISEASE RESISTANT TO INITIAL INTRAVENOUS IMMUNOGLOBULIN	*
dc.type	Article	*
dc.relation.issue	4	*
dc.relation.volume	35	*
dc.relation.index	SCI	*
dc.relation.index	SCIE	*
dc.relation.index	SCOPUS	*
dc.relation.startpage	457	*
dc.relation.lastpage	459	*
dc.relation.journaltitle	PEDIATRIC INFECTIOUS DISEASE JOURNAL	*
dc.identifier.doi	10.1097/INF.0000000000001039	*
dc.identifier.wosid	WOS:000372843600021	*
dc.identifier.scopusid	2-s2.0-84950152953	*
dc.author.google	Youn, Youngmin	*
dc.author.google	Kim, Jisoo	*
dc.author.google	Hong, Young Mi	*
dc.author.google	Sohn, Sejung	*
dc.contributor.scopusid	홍영미(35210025100;55841904000;56063366100)	*
dc.contributor.scopusid	손세정(56577409300)	*
dc.date.modifydate	20240415130647	*